Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Rank in Stocks #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Share Price
$0.0048574
Market Cap
$126.82K
Change (1 day)
0.00%
Change (1 year)
-21.82%
Country
IL
Trade BioLineRx Ltd. (BLRX)

Category

Dividend yield history for BioLineRx Ltd. (BLRX)
BioLineRx Ltd. (stock symbol: BLRX) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for BioLineRx Ltd. (BLRX) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors